HIV Therapeutics Market Report

China HIV Therapeutics Industry Market Research Report 2023-2029

  • POSTDATE：Sep 17, 2023
  • PAGES：176
  • REPORT CODE：GMM1805739
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS). AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Without treatment, average survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype. In most cases, HIV is a sexually transmitted infection and occurs by contact with or transfer of blood, pre-ejaculate, semen, and vaginal fluids. Non-sexual transmission can occur from an infected mother to her infant during pregnancy, during childbirth by exposure to her blood or vaginal fluid, and through breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells.

    This report elaborates on the current development of the HIV Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • GlaxoSmithKline

    • F Hoffmann-La Roche Ltd

    • Cipla Limited

    • Bristol-Myers Squibb

    • Boehringer Ingelheim International GmbH

    • Pfizer

    • Johnson & Johnson

    • AbbVie

    • ViiV Healthcare

    • Merck & Co

    By Type:

    • Protease Inhibitors (PIs)

    • Coreceptor Antagonists

    • Integrase Inhibitors

    • Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)

    • Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

    • Entry and Fusion Inhibitors

    By Application:

    • Clinics

    • Labs

    • Hospitals

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China HIV Therapeutics Market Overview 2018-2029

    • 1.1 China HIV Therapeutics Industry Development Overview

    • 1.2 China HIV Therapeutics Industry Development History

    • 1.3 China HIV Therapeutics Industry Market Size (2018-2029)

    • 1.4 China HIV Therapeutics Market Analysis by Type from Production Side

      • 1.4.1 China HIV Therapeutics Production Volume, Production Value and Growth Rate of Protease Inhibitors (PIs) (2018-2029)

      • 1.4.2 China HIV Therapeutics Production Volume, Production Value and Growth Rate of Coreceptor Antagonists (2018-2029)

      • 1.4.3 China HIV Therapeutics Production Volume, Production Value and Growth Rate of Integrase Inhibitors (2018-2029)

      • 1.4.4 China HIV Therapeutics Production Volume, Production Value and Growth Rate of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) (2018-2029)

      • 1.4.5 China HIV Therapeutics Production Volume, Production Value and Growth Rate of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) (2018-2029)

      • 1.4.6 China HIV Therapeutics Production Volume, Production Value and Growth Rate of Entry and Fusion Inhibitors (2018-2029)

    • 1.5 China HIV Therapeutics Market Analysis by Application from Consumption End

      • 1.5.1 China HIV Therapeutics Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

      • 1.5.2 China HIV Therapeutics Sales Volume, Sales Value and Growth Rate of Labs (2018-2029)

      • 1.5.3 China HIV Therapeutics Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • 1.6 China HIV Therapeutics Market Analysis by Region

      • 1.6.1 North China HIV Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China HIV Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China HIV Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China HIV Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China HIV Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China HIV Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China HIV Therapeutics Market Size and Growth Rate from 2018-2029

    Chapter 2 China HIV Therapeutics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on HIV Therapeutics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China HIV Therapeutics Market Status and Competition Analysis in 2023

      • 2.2.3 China HIV Therapeutics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China HIV Therapeutics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on HIV Therapeutics Industry Development

    Chapter 3 HIV TherapeuticsIndustry Chain Analysis

    • 3.1 HIV Therapeutics Industry Chain

    • 3.2 HIV Therapeutics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the HIV Therapeutics Market

    • 3.3 HIV Therapeutics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the HIV Therapeutics Market

    Chapter 4 China HIV Therapeutics Market, by Type

    • 4.1 China HIV Therapeutics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China HIV Therapeutics Total Production Volume and Growth Rate from Production Side

    • 4.5 China HIV Therapeutics Production Volume and Growth Rate, by Type

      • 4.5.1 China HIV Therapeutics Production Volume and Growth Rate of Protease Inhibitors (PIs)

      • 4.5.2 China HIV Therapeutics Production Volume and Growth Rate of Coreceptor Antagonists

      • 4.5.3 China HIV Therapeutics Production Volume and Growth Rate of Integrase Inhibitors

      • 4.5.4 China HIV Therapeutics Production Volume and Growth Rate of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)

      • 4.5.5 China HIV Therapeutics Production Volume and Growth Rate of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

      • 4.5.6 China HIV Therapeutics Production Volume and Growth Rate of Entry and Fusion Inhibitors

    Chapter 5 China HIV Therapeutics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China HIV Therapeutics Total Market Size and Growth Rate from Consumption End

    • 5.5 China HIV Therapeutics Market Size and Growth Rate, by Application

      • 5.5.1 China HIV Therapeutics Market Size and Growth Rate of Clinics

      • 5.5.2 China HIV Therapeutics Market Size and Growth Rate of Labs

      • 5.5.3 China HIV Therapeutics Market Size and Growth Rate of Hospitals

    Chapter 6 China HIV Therapeutics Market, by Region

    • 6.1 China HIV Therapeutics Production Volume and Production Value, by Region

    • 6.2 China HIV Therapeutics Sales Volume and Sales Value, by Region

    Chapter 7 North China HIV Therapeutics Market Analysis

    • 7.1 North China HIV Therapeutics Market, by Type

    • 7.2 North China HIV Therapeutics Market, by Application

    Chapter 8 Central China HIV Therapeutics Market Analysis

    • 8.1 Central China HIV Therapeutics Market, by Type

    • 8.2 Central China HIV Therapeutics Market, by Application

    Chapter 9 South China HIV Therapeutics Market Analysis

    • 9.1 South China HIV Therapeutics Market, by Type

    • 9.2 South China HIV Therapeutics Market, by Application

    Chapter 10 East China HIV Therapeutics Market Analysis

    • 10.1 East China HIV Therapeutics Market, by Type

    • 10.2 East China HIV Therapeutics Market, by Application

    Chapter 11 Northeast China HIV Therapeutics Market Analysis

    • 11.1 Northeast China HIV Therapeutics Market, by Type

    • 11.2 Northeast China HIV Therapeutics Market, by Application

    Chapter 12 Southwest China HIV Therapeutics Market Analysis

    • 12.1 Southwest China HIV Therapeutics Market, by Type

    • 12.2 Southwest China HIV Therapeutics Market, by Application

    Chapter 13 Northwest China HIV Therapeutics Market Analysis

    • 13.1 Northwest China HIV Therapeutics Market, by Type

    • 13.2 Northwest China HIV Therapeutics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 GlaxoSmithKline

        • 14.1.1 GlaxoSmithKline Company Profile

        • 14.1.2 GlaxoSmithKline HIV Therapeutics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 F Hoffmann-La Roche Ltd

        • 14.2.1 F Hoffmann-La Roche Ltd Company Profile

        • 14.2.2 F Hoffmann-La Roche Ltd HIV Therapeutics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Cipla Limited

        • 14.3.1 Cipla Limited Company Profile

        • 14.3.2 Cipla Limited HIV Therapeutics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Bristol-Myers Squibb

        • 14.4.1 Bristol-Myers Squibb Company Profile

        • 14.4.2 Bristol-Myers Squibb HIV Therapeutics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Boehringer Ingelheim International GmbH

        • 14.5.1 Boehringer Ingelheim International GmbH Company Profile

        • 14.5.2 Boehringer Ingelheim International GmbH HIV Therapeutics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Pfizer

        • 14.6.1 Pfizer Company Profile

        • 14.6.2 Pfizer HIV Therapeutics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Johnson & Johnson

        • 14.7.1 Johnson & Johnson Company Profile

        • 14.7.2 Johnson & Johnson HIV Therapeutics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 AbbVie

        • 14.8.1 AbbVie Company Profile

        • 14.8.2 AbbVie HIV Therapeutics Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 ViiV Healthcare

        • 14.9.1 ViiV Healthcare Company Profile

        • 14.9.2 ViiV Healthcare HIV Therapeutics Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Merck & Co

        • 14.10.1 Merck & Co Company Profile

        • 14.10.2 Merck & Co HIV Therapeutics Market Performance

        • 14.10.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 HIV Therapeutics Industry Research Conclusions

    • 15.2 HIV Therapeutics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China HIV Therapeutics Industry Market Size (2018-2029)

    • Figure China HIV Therapeutics Production Volume, Production Value and Growth Rate of Protease Inhibitors (PIs) (2018-2029)

    • Figure China HIV Therapeutics Production Volume, Production Value and Growth Rate of Coreceptor Antagonists (2018-2029)

    • Figure China HIV Therapeutics Production Volume, Production Value and Growth Rate of Integrase Inhibitors (2018-2029)

    • Figure China HIV Therapeutics Production Volume, Production Value and Growth Rate of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) (2018-2029)

    • Figure China HIV Therapeutics Production Volume, Production Value and Growth Rate of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) (2018-2029)

    • Figure China HIV Therapeutics Production Volume, Production Value and Growth Rate of Entry and Fusion Inhibitors (2018-2029)

    • Figure China HIV Therapeutics Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

    • Figure China HIV Therapeutics Sales Volume, Sales Value and Growth Rate of Labs (2018-2029)

    • Figure China HIV Therapeutics Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure North China HIV Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Central China HIV Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure South China HIV Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure East China HIV Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China HIV Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China HIV Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China HIV Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure HIV Therapeutics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China HIV Therapeutics Market Share by Type in 2018

    • Figure China HIV Therapeutics Market Share by Type in 2023

    • Figure China HIV Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China HIV Therapeutics Production Volume and Growth Rate of Protease Inhibitors (PIs) (2018-2023)

    • Figure China HIV Therapeutics Production Volume and Growth Rate of Coreceptor Antagonists (2018-2023)

    • Figure China HIV Therapeutics Production Volume and Growth Rate of Integrase Inhibitors (2018-2023)

    • Figure China HIV Therapeutics Production Volume and Growth Rate of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) (2018-2023)

    • Figure China HIV Therapeutics Production Volume and Growth Rate of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) (2018-2023)

    • Figure China HIV Therapeutics Production Volume and Growth Rate of Entry and Fusion Inhibitors (2018-2023)

    • Figure China HIV Therapeutics Market Share by Application in 2018

    • Figure China HIV Therapeutics Market Share by Application in 2023

    • Figure China HIV Therapeutics Total Market Size and Growth Rate from Consumption End

    • Figure China HIV Therapeutics Market Size and Growth Rate of Clinics (2018-2023)

    • Figure China HIV Therapeutics Market Size and Growth Rate of Labs (2018-2023)

    • Figure China HIV Therapeutics Market Size and Growth Rate of Hospitals (2018-2023)

    • Table China HIV Therapeutics Production Volume by Region (2018-2023)

    • Table China HIV Therapeutics Production Volume Share by Region (2018-2023)

    • Figure China HIV Therapeutics Production Volume Share by Region (2018-2023)

    • Table China HIV Therapeutics Production Value by Region (2018-2023)

    • Table China HIV Therapeutics Production Value Share by Region (2018-2023)

    • Figure China HIV Therapeutics Production Value Share by Region (2018-2023)

    • Table China HIV Therapeutics Sales Volume by Region (2018-2023)

    • Table China HIV Therapeutics Sales Volume Share by Region (2018-2023)

    • Figure China HIV Therapeutics Sales Volume Share by Region (2018-2023)

    • Table China HIV Therapeutics Sales Value by Region (2018-2023)

    • Table China HIV Therapeutics Sales Value Share by Region (2018-2023)

    • Figure China HIV Therapeutics Sales Value Share by Region (2018-2023)

    • Table North China HIV Therapeutics Production Volume by Type (2018-2023)

    • Table North China HIV Therapeutics Production Volume Share by Type (2018-2023)

    • Figure North China HIV Therapeutics Production Volume Share by Type (2018-2023)

    • Table North China HIV Therapeutics Sales Volume by Application (2018-2023)

    • Table North China HIV Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure North China HIV Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Central China HIV Therapeutics Production Volume by Type (2018-2023)

    • Table Central China HIV Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Central China HIV Therapeutics Production Volume Share by Type (2018-2023)

    • Table Central China HIV Therapeutics Sales Volume by Application (2018-2023)

    • Table Central China HIV Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Central China HIV Therapeutics Sales Volume Share by Application (2018-2023)

    • Table South China HIV Therapeutics Production Volume by Type (2018-2023)

    • Table South China HIV Therapeutics Production Volume Share by Type (2018-2023)

    • Figure South China HIV Therapeutics Production Volume Share by Type (2018-2023)

    • Table South China HIV Therapeutics Sales Volume by Application (2018-2023)

    • Table South China HIV Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure South China HIV Therapeutics Sales Volume Share by Application (2018-2023)

    • Table East China HIV Therapeutics Production Volume by Type (2018-2023)

    • Table East China HIV Therapeutics Production Volume Share by Type (2018-2023)

    • Figure East China HIV Therapeutics Production Volume Share by Type (2018-2023)

    • Table East China HIV Therapeutics Sales Volume by Application (2018-2023)

    • Table East China HIV Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure East China HIV Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northeast China HIV Therapeutics Production Volume by Type (2018-2023)

    • Table Northeast China HIV Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northeast China HIV Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northeast China HIV Therapeutics Sales Volume by Application (2018-2023)

    • Table Northeast China HIV Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China HIV Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Southwest China HIV Therapeutics Production Volume by Type (2018-2023)

    • Table Southwest China HIV Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Southwest China HIV Therapeutics Production Volume Share by Type (2018-2023)

    • Table Southwest China HIV Therapeutics Sales Volume by Application (2018-2023)

    • Table Southwest China HIV Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China HIV Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northwest China HIV Therapeutics Production Volume by Type (2018-2023)

    • Table Northwest China HIV Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northwest China HIV Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northwest China HIV Therapeutics Sales Volume by Application (2018-2023)

    • Table Northwest China HIV Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China HIV Therapeutics Sales Volume Share by Application (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline HIV Therapeutics Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche Ltd Company Profile

    • Table F Hoffmann-La Roche Ltd HIV Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Cipla Limited Company Profile

    • Table Cipla Limited HIV Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Profile

    • Table Bristol-Myers Squibb HIV Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim International GmbH Company Profile

    • Table Boehringer Ingelheim International GmbH HIV Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer HIV Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson HIV Therapeutics Revenue, Price and Gross (2018-2023)

    • Table AbbVie Company Profile

    • Table AbbVie HIV Therapeutics Revenue, Price and Gross (2018-2023)

    • Table ViiV Healthcare Company Profile

    • Table ViiV Healthcare HIV Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Merck & Co Company Profile

    • Table Merck & Co HIV Therapeutics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US